论文部分内容阅读
Objective To compare the efficacy and toxicities of combining homoharringtonine(HHT)±daunorubicin(DNR)with all-transretinoic acid(ATRA)based therapy and DNR plus ATRA based therapy in newly diagnosed low/intermediate risk acute promyelocytic leukemia(APL).Methods A total of 96 newly diagnosed pa-
Objective To compare the efficacy and toxicities of combining homoharringtonine (HHT) ± daunorubicin (DNR) with all-transretinoic acid (ATRA) based therapy and DNR plus ATRA based therapy in newly diagnosed low / intermediate risk acute promyelocytic leukemia (APL). Methods A total of 96 newly diagnosed pa-